Showing 721 - 740 results of 8,139 for search '"elevation"', query time: 0.08s Refine Results
  1. 721
  2. 722
  3. 723

    Elevated Plasma Soluble Triggering Receptor Expressed on Myeloid Cells-1 Level in Patients with Acute Coronary Syndrome (ACS): A Biomarker of Disease Severity and Outcome by Shachaf Shiber, Vitaly Kliminski, Katia Orvin, Iftach Sagy, Mordehay Vaturi, Ran Kornowski, Michael Drescher, Yair Molad

    Published 2021-01-01
    “…Plasma sTREM-1 levels are significantly elevated in patients with ACS and might serve as a biomarker differentiating ACS from NSCP in the ED as well as an inflammatory biomarker for coronary artery disease severity and outcome.…”
    Get full text
    Article
  4. 724

    Visfatin Related to the Severity of Non-ST-Segment Elevation Acute Coronary Syndrome: A Retrospective Study of 164 Patients at a Tertiary Chest Pain Center by Meifan Zheng, Zhongwei Wu, Chaoquan Liu, Fei Xiao

    Published 2024-01-01
    “…Acute coronary syndrome (ACS) poses a pervasive threat to individuals grappling with cardiovascular afflictions, manifesting as unstable angina, non-ST-segment elevation myocardial infarction (NSTEMI), ST-segment elevation myocardial infarction (STEMI), or sudden cardiac death, depending on vascular obstruction’s extent and location. …”
    Get full text
    Article
  5. 725
  6. 726
  7. 727
  8. 728
  9. 729
  10. 730
  11. 731
  12. 732

    Hemolysis, Elevated Liver Enzymes, and Low Platelets, Severe Fetal Growth Restriction, Postpartum Subarachnoid Hemorrhage, and Craniotomy: A Rare Case Report and Systematic Review by Shadi Rezai, Justin Faye, Alexander Hughes, Mon-Lai Cheung, Joel R. Cohen, Judy A. Kaia, Paul N. Fuller, Cassandra E. Henderson

    Published 2017-01-01
    “…Introduction. Hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome is a relatively uncommon but traumatic condition occurring in the later stage of pregnancy as a complication of severe preeclampsia or eclampsia. …”
    Get full text
    Article
  13. 733
  14. 734
  15. 735
  16. 736

    Change in Growth Differentiation Factor 15, but Not C-Reactive Protein, Independently Predicts Major Cardiac Events in Patients with Non-ST Elevation Acute Coronary Syndrome by Alberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez, Idaira F. Hernandez-Baldomero, Pablo Avanzas, Francisco Bosa-Ojeda

    Published 2014-01-01
    “…The aims of our study are: (a) to describe the changes in hsCRP and GDF-15 levels over a period of time and after an episode of non-ST-segment elevation acute coronary syndrome (NSTE-ACS) and (b) to examine whether the rate of change in hsCRP and GDF-15 after the acute event is associated with long-term major cardiovascular adverse events (MACE). …”
    Get full text
    Article
  17. 737
  18. 738
  19. 739
  20. 740